- Title
- SECuRE: A dose escalation/expansion study to assess the anti-tumor efficacy of Cu-SAR-bisPSMA in patients with metastatic castrate-resistant prostate cancer
- Creators
- Geoffrey Johnson - Mayo ClinicEva Lengyelova - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaLuke T. Nordquist - Urology Cancer Center PC, Omaha, NE, United StatesVikas Prasad - Washington University in St. LouisMonique Anderson - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaOthon Gervasio - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaMichelle Parker - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaRobert M. Miller - Clarity Pharmaceuticals, Eveleigh, NSW, AustraliaA. Oliver Sartor - Mayo ClinicScott T. Tagawa - Cornell University
- Publication Details
- Journal of clinical oncology, Vol.42(4), pp.TPS246-TPS246
- Grant note
- Clarity Pharmaceuticals
- Identifiers
- 991006262307702656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
SECuRE: A dose escalation/expansion study to assess the anti-tumor efficacy of Cu-SAR-bisPSMA in patients with metastatic castrate-resistant prostate cancer
Journal of clinical oncology, Vol.42(4), pp.TPS246-TPS246
2024
Metrics
1 Record Views